Use of outcome measures in pulmonary hypertension clinical trials
- 1 September 2015
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 170 (3) , 419-429.e3
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- Pulmonary Artery Denervation to Treat Pulmonary Arterial HypertensionJACC, 2013
- Macitentan and Morbidity and Mortality in Pulmonary Arterial HypertensionNew England Journal of Medicine, 2013
- Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial HypertensionCardiovascular Therapeutics, 2013
- Biomarkers and surrogate endpoints in clinical trialsStatistics in Medicine, 2012
- Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionCirculation, 2011
- Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial HypertensionCirculation, 2011
- The DEDUCE Guided Query tool: Providing simplified access to clinical data for research and quality improvementJournal of Biomedical Informatics, 2011
- Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial HypertensionJournal of Cardiac Failure, 2010
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJACC, 2009
- Surrogate End Points in Pulmonary Arterial Hypertension: Assessing the Response to TherapyClinics in Chest Medicine, 2007